RxDoctor Payments DataLook up a doctor →

Rohit Goyal, MD

Critical Care Medicine · Fredericksburg, VANPI 1881879724

Payments from drug & device makers

$95,201in general payments, 2019–2025

Across 694 payments — averaging $137.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pulmonx Corporation$63K
  • Intuitive Surgical$8K
  • United Therapeutics Corporation$7K
  • AstraZeneca$2K
  • Johnson & Johnson$2K
  • GSK$2K
  • plus $11K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pulmonx Corporation39$63,479
Intuitive Surgical21$8,345
United Therapeutics Corporation27$6,790
AstraZeneca(2 entities)89$2,051
Johnson & Johnson(2 entities)23$2,004
GSK106$1,630
Noah Medical Corporation2$1,073
Boehringer Ingelheim56$1,053
Olympus Corporation Of The Americas8$1,039
ANI Pharmaceuticals, Inc.31$810
Takeda Pharmaceuticals U.S.A., Inc.27$783
Insmed, Inc.39$721
Sanofi27$711
Mallinckrodt Hospital Products Inc.15$524
Amgen21$426
Actelion Pharmaceuticals US, Inc.16$394
Regeneron Healthcare Solutions, Inc.10$312
Harmony Biosciences LLC9$272
Lilly USA, LLC2$247
Grifols USA, LLC10$223
Pfizer11$205
Shionogi Inc14$187
Bayer9$177
Sanofi-aventis U.S. LLC2$160
Verona Pharma, Inc.6$114
Inspire Medical Systems, Inc.2$111
Getinge USA Sales, LLC2$96
Mylan Specialty L.p.6$95
Jazz Pharmaceuticals Inc.4$94
Sunovion Pharmaceuticals Inc.6$85
Merck4$81
Electromed, Inc.5$79
Baxter Healthcare3$79
Vifor Pharma, Inc.4$76
Axsome Therapeutics, Inc.3$67
Gilead4$64
Viatris Specialty LLC3$57
Teva Pharmaceuticals USA, Inc.4$55
Genentech USA, Inc.3$52
Mallinckrodt Enterprises LLC3$47
Avadel CNS Pharmaceuticals, LLC2$42
Paratek Pharmaceuticals, Inc.2$39
Astellas Pharma US Inc2$34
Vanda Pharmaceuticals Inc.1$32
Philips North America LLC2$30
Melinta Therapeutics, LLC1$28
Portola Pharmaceuticals, LLC1$26
Novartis1$25
Cumberland Pharmaceuticals, Inc.2$22
Idorsia Pharmaceuticals US Inc1$18
Circassia Inc.1$15
Shire North American Group Inc1$12
Chiesi USA, Inc.1$11

How this compares

$95,201 in reported general payments places this provider in the 90th percentile of 174 critical care medicine providers in Virginia.

See all critical care medicine providers in Virginia →

Medicare billing

Part B allowed, 2024
$1,152,513
Medicare patients
1,733
Services billed
18,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Fredericksburg

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →